Author Topic: Fluvoxamine: Dealing with the effects of COVID-19  (Read 302 times)

adroth

  • Administrator
  • Boffin
  • *****
  • Posts: 13168
    • View Profile
    • The ADROTH Project
Fluvoxamine: Dealing with the effects of COVID-19
« on: April 04, 2021, 01:51:22 PM »
Finding a possible early treatment for COVID-19 in a 40-year-old antidepressant

Sharyn Alfonsi reports on the unusual path fluvoxamine, a drug commonly used to treat obsessive-compulsive disorder, has had to becoming an early treatment candidate for COVID-19.

https://www.cbsnews.com/news/fluvoxamine-antidepressant-drug-covid-treatment-60-minutes-2021-03-07/

The race to find vaccines for COVID-19 has dominated the headlines, but there's been less news about how to keep people with COVID out of the hospital. Tonight, we're going to tell you a story about one possible treatment. It's called fluvoxamine. The generic drug was developed 40 years ago as an antidepressant and has been primarily used to treat obsessive-compulsive disorder. Now, a small but ingenious clinical trial and a series of coincidences have led scientists to look closely at fluvoxamine as a possible tool to keep newly diagnosed COVID-19 patients from becoming severely ill. So how did a pill that costs 60 cents become a dark horse to treat COVID? We went to a place that knows all about long shots to find out.

Golden Gate Fields is in Berkeley, California. The stands have been empty since COVID hit last year, but the races go on. There are 1,200 thoroughbreds here trained and cared for by more than 500 people. Last November, COVID went on a rampage in the barn area where many workers live.

< Edited >

adroth

  • Administrator
  • Boffin
  • *****
  • Posts: 13168
    • View Profile
    • The ADROTH Project
Re: Fluvoxamine: Dealing with the effects of COVID-19
« Reply #1 on: April 04, 2021, 01:54:15 PM »
Doctors test popular anti-depressant to see if it fights off COVID-19
By CNN Philippines Staff

Published Jan 12, 2021 8:21:00 AM

https://cnnphilippines.com/world/2021/1/12/COVID-19-treatment-anti-depressant-fluvoxamine-Luvox.html

(CNN) Doctors are running a clinical trial to see if a popular anti-depressant might keep someone from becoming severely ill with COVID-19.

The researchers at Washington University of St. Louis are recruiting 1,100 people in the beginning stages of COVID-19 to test out the drug fluvoxamine, also known as Luvox.

While an anti-depressant may seem like an unlikely candidate to fight Covid-19, a small study in November indicated it might have some success, and it's been known for years that modern anti-depressants, called selective serotonin reuptake inhibitors, have anti-inflammatory properties. Inflammation plays a key role in Covid-19, resulting in complications such as blood clots and swollen "Covid toes."

< Edited >